{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:47:13Z","timestamp":1773157633688,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,1,30]],"date-time":"2007-01-30T00:00:00Z","timestamp":1170115200000},"content-version":"vor","delay-in-days":3073,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pineal Research"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We have studied the effect of the administration of two doses of melatonin (melatonin 100 and melatonin 200 \u03bcg\/kg bw) on diabetes and oxidative stress experimentally induced by the injection of streptozotocin (STZ) in female Wistar rats. STZ was injected as a single dose (60 mg\/kg i.p. in buffered citrate solution, pH 4.0) and melatonin (melatonin 100, 100 \u03bcg\/kg\/day i.p.; melatonin 200, 200 \u03bcg\/kg\/day i.p.) beginning 3 days before diabetes induction and continuing until the end of the study (8 weeks). The parameters analysed to evaluate oxidative stress and the diabetic state were a) for oxidative stress, changes of lipoperoxides (i.e., malondialdehyde, MDA) in plasma and erythrocytes and the changes in reduced glutathione (GSH) in erythrocytes and b) for diabetes, changes in glycemia, lipids (triglycerides: TG; total cholesterol: TC; HDL\u2010cholesterol, HDL\u2010c), percentage of glycosylated hemoglobin (Hb%), and plasma fructosamine. The injection of STZ caused significant increases in the levels of glycemia, percentage of glycosylated hemoglobin, fructosamine, cholesterol, triglycerides, and lipoperoxides in plasma and erythrocytes, whereas it decreased the levels of HDL\u2010c and the GSH content in erythrocytes. The melatonin 100 dose reduced significantly all these increases, except the percentage of glycosylated hemoglobin. With regard to the decreases of plasma HDL\u2010c and GSH content in erythrocytes, this melatonin dose returned them to normal levels. The melatonin 200 dose produced similar changes, though the effects were especially noticeable in the decrease of glycemia (55% vs. diabetes), percentage of hemoglobin (<jats:italic>P<\/jats:italic> &lt; 0.001 vs diabetes), and fructosamine (31% vs. diabetes). This dose also reversed the decreases of HDL\u2010c and GSH in erythrocytes. Both doses of melatonin caused significant reduction of the percentage of glycosylated hemoglobin in those groups that were non\u2010diabetic. These illustrate the protective effect of melatonin against oxidative stress and the severity of diabetes induced by STZ. In particular, this study confirms two facts: 1) the powerful antioxidant action of this pineal indole and 2) the importance of the severity of oxidative stress to maintain hyperglycemia and protein glycosylation, two pathogenetic cornerstones indicative of diabetic complications. Melatonin reduces remarkably the degree of lipoperoxidation, hyperglycemia, and protein glycosylation, which gives hope to a promising perspective of this product, together with other biological antioxidants, in the treatment of diabetic complications where oxidative stress, either in a high or in a low degree, is present.<\/jats:p>","DOI":"10.1111\/j.1600-079x.1998.tb00545.x","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T21:05:15Z","timestamp":1170450315000},"page":"94-100","source":"Crossref","is-referenced-by-count":118,"title":["Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin"],"prefix":"10.1111","volume":"25","author":[{"given":"Pedro L\u00f3pez","family":"Montilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Fresno","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac Fi\u00f1ana","family":"T\u00fanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu\u00f1oz","family":"de Agueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. El\u00edas D\u00edaz","family":"Valdelvira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio S\u00e3nchez","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2337\/diab.45.11.1489","article-title":"Glycation of insulin in the islets of Langerhans of normal and diabetic animals","volume":"45","author":"Abdel\u2010Wahab Y.H.","year":"1996","journal-title":"Diabetes"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00921959"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-0186(94)00154-M"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.4.405"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1997.tb00339.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1993.tb00131.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00262-5"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.1.68"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.2.194"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.10.1589"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1995.tb00180.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.3.257"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.5.646"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2560205"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.11.1420"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0021-9258(19)77928-9","article-title":"Mechanism of oxidant\u2010mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide","volume":"263","author":"Hyslop P. A.","year":"1988","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_18_1","first-page":"147","article-title":"Melatonin involvement in oxidative stress","volume":"29","author":"Ianas O.","year":"1991","journal-title":"Rom. J. Endocrinol."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1997.tb00323.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1997.tb00312.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2337\/diab.38.3.379","article-title":"Oxygen free radicals scavengers and immune destruction of murine allograft rejection and multiple low\u2010dose streptozotocin\u2010induced insulitis","volume":"38","author":"Mendiola J.","year":"1987","journal-title":"Diabetes"},{"key":"e_1_2_1_23_1","first-page":"149","article-title":"Lipoperoxidos en la diabetes por estrep\u2010tozotocina en ratas: Efectos de la administracion de insu\u2010lina","volume":"4","author":"Montilla P.","year":"1992","journal-title":"Clin. Invest. Arteriosclerosis"},{"key":"e_1_2_1_24_1","first-page":"114","article-title":"Curso evolutivo de la glucosa, fructosamina y lipoperoxidos plasmaticos en ratas diabeticas por estreptozotocina. Efecto de la vitamina E","volume":"5","author":"Munoz M. C.","year":"1993","journal-title":"Clin. Invest. Arteriosclerosis"},{"key":"e_1_2_1_25_1","first-page":"211","article-title":"Antioxidant activity of melatonin mice","volume":"80","author":"Plerrefiche G.","year":"1993","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00532-X"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1997.tb00333.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1995.1014"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1340412"},{"key":"e_1_2_1_30_1","first-page":"103","article-title":"Antioxidant capacity of melatonin: Nobel action not requiring receptor","volume":"15","author":"Reiter R.J.","year":"1993","journal-title":"Neuro-endocrinol. Lett."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00030-1"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2820055"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(82)90237-5"},{"key":"e_1_2_1_34_1","first-page":"57","article-title":"Melatonin: a potent, endogenous hydroxyl radical scavenger","volume":"1","author":"Tan D.X.","year":"1993","journal-title":"Endocrine J."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(61)90145-0"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111960"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.2.S14"}],"container-title":["Journal of Pineal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-079X.1998.tb00545.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-079X.1998.tb00545.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:38:35Z","timestamp":1698464315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-079X.1998.tb00545.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1111\/j.1600-079X.1998.tb00545.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-079x.1998.tb00545.x","archive":["Portico"],"relation":{},"ISSN":["0742-3098","1600-079X"],"issn-type":[{"value":"0742-3098","type":"print"},{"value":"1600-079X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}